# PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases

> **NCT01125605** · — · COMPLETED · sponsor: **Pascoe Pharmazeutische Praeparate GmbH** · enrollment: 325 (actual)

## Conditions studied

- Nervousness
- Sleep Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01125605
- **Lead sponsor:** Pascoe Pharmazeutische Praeparate GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 325 (ACTUAL)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125605, "PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01125605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*